Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

The document covers various male health issues, their causes, treatments, and related conditions.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Androgens can both increase and decrease hair growth in different parts of the body.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Understanding hair biology is key to developing better treatments for hair and scalp issues.